Longevity & Cellular Defense Research
The cellular defense and antioxidant chemistry behind our longevity research line.
How This Works
Longevity research in this category covers three distinct mechanisms: copper-peptide-driven tissue signaling (GHK-Cu, shared with the aesthetics line), a small tetrapeptide studied for telomerase and epigenetic effects (Epitalon), and two of the most heavily marketed cellular-defense molecules in wellness research (Glutathione, NAD+) — both of which, notably, have real human trial data showing more modest effects than their popular reputation suggests. This category is a useful illustration of why reading the primary literature matters: several of its compounds have genuine mechanistic plausibility but thin or mixed human clinical evidence.
Compounds Behind This Category
GHK-Cu
GHK-Cu is a naturally occurring copper-binding tripeptide whose plasma concentration declines with age. In dermal fibroblast and keratinocyte research, it stimulates collagen and glycosaminoglycan synthesis, promotes angiogenesis, and has chemotactic effects on immune cells, and it has been shown to influence broad gene-expression programs linked to tissue remodeling and wound repair.
ExploreEpitalon (Epithalon)
Epitalon (the AEDG tetrapeptide) has been studied for inducing telomerase catalytic-subunit expression and telomere elongation in telomerase-negative human fibroblast cultures, and for normalizing circadian melatonin and cortisol secretion in aged primates. Molecular modeling suggests it may bind histone H1 sites to epigenetically regulate transcription. Its telomerase-inducing effect raises a theoretical oncogenesis concern — telomerase reactivation is a hallmark of many cancers — though the origin research group's own animal work reports decreased experimental carcinogenesis with treatment, a tension not yet independently resolved outside that group. No completed human clinical safety trials were identified; the evidence base is limited to in vitro and animal studies from a small number of research groups.
ExploreGlutathione
Glutathione is the most abundant intracellular low-molecular-weight thiol and the major cellular redox buffer, serving as the essential cofactor for glutathione peroxidase (neutralizing peroxides) and glutathione-S-transferases (hepatic xenobiotic conjugation and clearance). A randomized, placebo-controlled trial of IV glutathione in Parkinson's disease found it well tolerated with no significant difference in adverse events from placebo, but no statistically significant motor-symptom benefit. IV glutathione used off-label for skin lightening has documented adverse effects sufficient to prompt a public regulatory warning against that specific use.
ExploreNAD+ (Nicotinamide Adenine Dinucleotide)
NAD+ is a coenzyme present in all living cells that shuttles electrons in the redox reactions central to glycolysis, the TCA cycle, and oxidative phosphorylation. It is also a consumed co-substrate for PARP enzymes during DNA base-excision repair and for sirtuins during protein deacetylation, linking cellular NAD+ availability to genome-stability maintenance and metabolic regulation. Cellular NAD+ levels decline with age. A systematic review of 8 randomized trials of the precursor NMN (342 participants) found no significant benefit on glucose, insulin, or lipid markers, and a separate review of 25 published human trials of the precursor NR concluded supplementation has shown few clinically relevant effects — an important gap between preclinical claims and confirmed human outcomes.
Explore